These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 392806)

  • 1. The paradoxical thrombogenic effect of aspirin in experimental thrombosis.
    Zimmerman R; Thiessen M; Mörl H; Weckesser G
    Thromb Res; 1979; 16(5-6):843-6. PubMed ID: 392806
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of anticoagulation and inhibition of platelet aggregation on arterial versus venous microvascular thrombosis.
    Li X; Cooley BC
    Ann Plast Surg; 1995 Aug; 35(2):165-9; discussion 169-70. PubMed ID: 7486739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombogenic effect of high-dose aspirin in rabbits. Relationship to inhibition of vessel wall synthesis of prostaglandin I2-like activity.
    Kelton JG; Hirsh J; Carter CJ; Buchanan MR
    J Clin Invest; 1978 Oct; 62(4):892-5. PubMed ID: 359598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suloctidil: a novel inhibitor of platelet aggregation in human beings.
    de Gaetano G; Miragliotta G; Roncucci R; Lansen J; Lambelin G
    Thromb Res; 1976 Mar; 8(3):361-71. PubMed ID: 1265708
    [No Abstract]   [Full Text] [Related]  

  • 5. Paradoxical effect of high and low dose aspirin in experimental arterial thrombosis.
    Zimmermann R; Thiessen M; Walter E; Mörl H
    Artery; 1980; 8(5):422-5. PubMed ID: 7213048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral aspirin dose on platelet aggregation and arterial prostacyclin synthesis: studies in humans and rabbits.
    Ellis EF; Jones PS; Wright KF; Richardson DW; Ellis CK
    Adv Prostaglandin Thromboxane Res; 1980; 6():313-5. PubMed ID: 6770601
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhanced platelet accumulation onto injured carotid arteries in rabbits after aspirin treatment.
    Buchanan MR; Dejana E; Gent M; Mustard JF; Hirsch J
    J Clin Invest; 1981 Feb; 67(2):503-8. PubMed ID: 7007438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of thrombosis and enhancement of thrombolysis in rabbits by SR 121787, a glycoprotein II/III antagonist.
    Hoffmann P; Bernat A; Savi P; Herbert JM
    J Pharmacol Exp Ther; 1998 Aug; 286(2):670-5. PubMed ID: 9694919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antithrombotic activity of RU-891 antiaggregant agent].
    Spasov AA; Kucheriavenko AF; Tian' M; Anisimova VA
    Eksp Klin Farmakol; 2013; 76(6):25-6. PubMed ID: 24003486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin.
    Moncada S; Korbut R
    Lancet; 1978 Jun; 1(8077):1286-9. PubMed ID: 78050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic activity of Z4A5, a new platelet glycoprotein IIb/IIIa receptor antagonist evaluated in a rabbit arteriovenous shunt thrombosis model.
    Jing BB; Li YX; Zhang H; Ren ST; Wang M; Li YP; Zang WJ; Wang B
    Thromb Res; 2011 Nov; 128(5):463-9. PubMed ID: 21924458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo method for quantitation for anti-platelet potency of drugs.
    Gryglewski RJ; Korbut R; Ocetkiewicz A; Stachura J
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Mar; 302(1):25-30. PubMed ID: 652049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostacyclin (PGI2) and thromboxane A2 interaction in vivo. Regulation by aspirin and relationship with anti-thrombotic therapy.
    Korbut R; Moncada S
    Thromb Res; 1978 Sep; 13(3):489-500. PubMed ID: 369028
    [No Abstract]   [Full Text] [Related]  

  • 14. The antiaggregating and antithrombotic activity of ticlopidine is potentiated by aspirin in the rat.
    Herbert JM; Bernat A; Samama M; Maffrand JP
    Thromb Haemost; 1996 Jul; 76(1):94-8. PubMed ID: 8819259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic activity of a polydeoxyribonucleotidic substance extracted from mammalian organs: a possible link with prostacyclin.
    Niada R; Mantovani M; Prino G; Pescador R; Berti F; Omini C; Folco GC
    Thromb Res; 1981 Aug; 23(3):233-46. PubMed ID: 7029778
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of oral aspirin dose on platelet aggregation and vascular prostacyclin (PGI2) synthesis in humans and rabbits.
    Ellis EF; Wright KF; Jones PS; Richardson DW; Ellis CK
    J Cardiovasc Pharmacol; 1980; 2(4):387-97. PubMed ID: 6156337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antithrombotic activity of BAY g 6575.
    Seuter F; Busse WD; Meng K; Hoffmeister F; Möller E; Horstmann H
    Arzneimittelforschung; 1979; 29(1):54-9. PubMed ID: 375948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of acetylsalicyclic and nicotinic acids and complamin on the formation of a prostacyclin-like substance by the aortic wall].
    Lakin KM; Baluda VP; Lukoianova TI; Romanovskaia VN; Baluda MV
    Farmakol Toksikol; 1980; 43(5):581-5. PubMed ID: 7004908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cilostazol on platelet aggregation and experimental thrombosis.
    Kimura Y; Tani T; Kanbe T; Watanabe K
    Arzneimittelforschung; 1985; 35(7A):1144-9. PubMed ID: 4074426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of "anti-platelet" drugs on bleeding time and platelet aggregation in normal human subjects.
    Buchanan GR; Martin V; Levine PH; Scoon K; Handin RI
    Am J Clin Pathol; 1977 Sep; 68(3):355-9. PubMed ID: 331937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.